Contact Us
Polymerase Chain Reaction Molecular Diagnostics Global Market Report 2025
Global Polymerase Chain Reaction Molecular Diagnostics Market Report 2025
Item added to cart!

Published : December 2025

Pages : 200

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Purchase This Report Download Sample PDF
Purchase This Report

Polymerase Chain Reaction Molecular Diagnostics Global Market Report 2025

By Product Type (Instrument, Reagents And Consumables, Software), By Technology ( Real-Time Polymerase Chain Reaction, Digital Polymerase Chain Reaction, Conventional Polymerase Chain Reaction), By Sample Type (Blood Samples, Saliva Samples, Tissue Samples, Urine Samples), By Application (Infectious Disease Testing, Oncology Testing, Other Applications), By End-User (Hospitals, Diagnostic Laboratories, Other End Users) – Impact of Tariff and Trade War on Market Size, Growth, Trends, and Forecast 2025–2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Polymerase Chain Reaction Molecular Diagnostics Market Overview

• Polymerase Chain Reaction Molecular Diagnostics market size has reached to $8.97 billion in 2024

• Expected to grow to $13.54 billion in 2029 at a compound annual growth rate (CAGR) of 8.6%

• Growth Driver: Rising Prevalence Of Infectious Diseases Fueling The Growth Of The Market Due To Increasing Need For Early And Accurate Pathogen Detection

• Market Trend: Advancements in Digital Technology Enhance Precision and Speed in Disease Detection

North America was the largest region in 2024 and Asia-Pacific is the fastest growing region.

What Is Covered Under Polymerase Chain Reaction Molecular Diagnostics Market?

Polymerase chain reaction (PCR) molecular diagnostics is a laboratory technique used to amplify and analyze specific deoxyribonucleic acid or ribonucleic acid sequences in a sample. Its main purpose is to detect the presence of specific genetic material, enabling the identification of pathogens, genetic disorders, or mutations. It is widely used in medical diagnostics for detecting infectious diseases, genetic disorders, and cancer markers with high sensitivity and accuracy.

The main product types of polymerase chain reaction molecular diagnostics are Instruments, reagents and consumables, and software. Instruments refer to tools or devices designed to perform specific tasks, measurements, or operations, typically in scientific, medical, or technical fields. These technologies encompass real-time polymerase chain reaction, digital polymerase chain reaction, and conventional polymerase chain reaction for sample types including blood, saliva, tissue, and urine samples. Polymerase chain reaction molecular diagnostics are applied in areas such as infectious disease testing, oncology testing, and others, and are used by several end-users, including hospitals, diagnostic laboratories, and various others.

Polymerase Chain Reaction Molecular Diagnostics Market Size and growth rate 2025 to 2029: Graph

What Is The Polymerase Chain Reaction Molecular Diagnostics Market Size 2025 And Growth Rate?

The polymerase chain reaction molecular diagnostics market size has grown strongly in recent years. It will grow from $8.97 billion in 2024 to $9.75 billion in 2025 at a compound annual growth rate (CAGR) of 8.6%. The growth in the historic period can be attributed to increasing demand for early disease detection, increasing prevalence of infectious diseases, increasing awareness of genetic disorders, rising adoption of point-of-care testing, and increasing incidence of chronic diseases.

What Is The Polymerase Chain Reaction Molecular Diagnostics Market Growth Forecast?

The polymerase chain reaction molecular diagnostics market size is expected to see strong growth in the next few years. It will grow to $13.54 billion in 2029 at a compound annual growth rate (CAGR) of 8.6%. The growth in the forecast period can be attributed to the rising prevalence of cancer, growing demand for personalized medicine, increasing investments in molecular diagnostics, rising demand for rapid diagnostic tests, and growing demand for non-invasive prenatal testing. Major trends in the forecast period include the advancement of diagnostic technologies, the development of point-of-care polymerase chain reaction systems, innovation in multiplex polymerase chain reaction, the integration of polymerase chain reaction with microfluidics, and technology upgrades in digital polymerase chain reaction platforms.

The forecast of 8.6% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Trade tensions could hinder U.S. adoption of high-throughput Polymerase Chain Reaction systems by inflating prices of automated extraction kits and thermal cyclers developed in Japan and South Korea, resulting in reduced testing capacity and higher infectious disease management costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

Customer representative image Book your 30 minutes free consultation with our research experts

What’s The Trade War Impact On Healthcare Services Industry?

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

How Is The Polymerase Chain Reaction Molecular Diagnostics Market Segmented?

1) By Product Type: Instrument, Reagents And Consumables, Software

2) By Technology: Real-Time Polymerase Chain Reaction, Digital Polymerase Chain Reaction, Conventional Polymerase Chain Reaction

3) By Sample Type: Blood Samples, Saliva Samples, Tissue Samples, Urine Samples

4) By Application: Infectious Disease Testing, Oncology Testing, Other Applications

5) By End-User: Hospitals, Diagnostic Laboratories, Other End Users

Subsegments:

1) By Instrument: Standard Polymerase Chain Reaction Systems, Digital Polymerase Chain Reaction Systems, Real-Time Polymerase Chain Reaction Systems

2) By Reagents And Consumables: Polymerase Chain Reaction Kits, Polymerase Chain Reaction Enzymes, Polymerase Chain Reaction Primers and Probes, Polymerase Chain Reaction Master Mix

3) By Software: Polymerase Chain Reaction Analysis Software, Data Management Software

What Is Driving The Polymerase Chain Reaction Molecular Diagnostics Market? Rising Prevalence Of Infectious Diseases Fueling The Growth Of The Market Due To Increasing Need For Early And Accurate Pathogen Detection

The rising prevalence of infectious diseases is expected to propel the growth of the polymerase chain reaction molecular diagnostics market going forward. Infectious diseases refer to illnesses caused by harmful microorganisms such as bacteria, viruses, fungi, or parasites that can spread directly or indirectly from one person to another. The prevalence of infectious diseases is increasing due to the emergence of antibiotic-resistant pathogens, which are harder to treat and control, leading to prolonged illness, higher healthcare costs, and greater public health risks. Polymerase chain reaction (PCR) molecular diagnostics enhance infectious disease management by providing rapid, accurate detection of pathogens at the genetic level, enabling early diagnosis and targeted treatment. This improves healthcare outcomes by facilitating timely interventions, reducing the spread of infections, and optimizing patient care. For instance, in November 2023, according to the Department of Health and Human Services, a US-based government department, the newly reported chronic hepatitis B (a viral infection that affects the liver and can lead to both acute and chronic disease) cases rose by 11% in 2022 compared to 2021. Therefore, the rising prevalence of infectious diseases is driving the growth of the polymerase chain reaction molecular diagnostics industry.

Who Are The Major Players In The Global Polymerase Chain Reaction Molecular Diagnostics Market?

Major companies operating in the polymerase chain reaction molecular diagnostics market are F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Becton Dickinson and Company, Laboratory Corporation of America Holdings, Agilent Technologies Inc., Grifols S.A., Illumina Inc., Endress + Hauser AG, bioMereieux SA, Sysmex Corporation, Bio-Rad Laboratories Inc., QuidelOrtho Corporation, PerkinElmer, Eppendorf AG, Tecan Group, Takara Bio Inc., Biocartis NV, Zymo Research Corporation.

What Are The Key Trends Of The Global Polymerase Chain Reaction Molecular Diagnostics Market? Advancements in Digital Technology Enhance Precision and Speed in Disease Detection

Major companies in the polymerase chain reaction molecular diagnostics market are focusing on developing technologically advanced solutions such as benchtop instruments to enhance testing efficiency and accessibility. Benchtop instruments refer to compact, laboratory-grade devices that are small enough to fit on a workbench or table and are used for scientific, medical, or industrial testing and analysis. For instance, in September 2024, QIAGEN N.V., a Germany-based biotechnology company, launched the QIAcuityDx Digital PCR System for clinical testing in oncology. These system features are fully automated, walk-away processing that integrates partitioning, thermocycling, and imaging into a single instrument, delivering absolute quantification of deoxyribonucleic acid and ribonucleic acid with results in about two hours and minimal hands-on time. The system supports up to five detection channels for multiplexing and continuous nanoplate loading and offers both validated and flexible research modes, making it adaptable for diverse clinical and laboratory needs.

Need data on a specific region in this market?

What Are Latest Mergers And Acquisitions In The Polymerase Chain Reaction Molecular Diagnostics Market? Bruker Corporation Acquires ELITechGroup To Expand Molecular Diagnostic Capabilities

In May 2024, Bruker Corporation, a US-based manufacturer of high-end analytical instruments, acquired ELITechGroup for $930.9 million. With this acquisition, Bruker Corporation aims to strengthen its position in infectious disease diagnostics by expanding its molecular diagnostic capabilities and product portfolio to better serve clinical laboratories and hospitals globally. ELITech Group SAS is an Italy-based in-vitro diagnostics company that specializes in polymerase chain reaction (PCR) molecular diagnostics.

What Is The Regional Outlook For The Global Polymerase Chain Reaction Molecular Diagnostics Market?

North America was the largest region in the polymerase chain reaction molecular diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Polymerase Chain Reaction Molecular Diagnostics Market?

The polymerase chain reaction molecular diagnostics market consists of revenues earned by entities by providing services such as infectious disease testing, genetic disorder screening, pharmacogenomics testing, deoxyribonucleic acid amplification services, and viral load monitoring. The market value includes the value of related goods sold by the service provider or included within the service offering. The polymerase chain reaction molecular diagnostics market also includes sales of thermal cyclers, electrophoresis systems, assay kits, and reverse transcriptase enzymes. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Polymerase Chain Reaction Molecular Diagnostics Industry?

The polymerase chain reaction molecular diagnostics market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the polymerase chain reaction molecular diagnostics industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abdul Wasay

Polymerase Chain Reaction Molecular Diagnostics Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2025 $9.75 billion
Revenue Forecast In 2034 $13.54 billion
Growth Rate CAGR of 8.6% from 2025 to 2034
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered The polymerase chain reaction molecular diagnostics market covered in this report is segmented –
1) By Product Type: Instrument, Reagents And Consumables, Software
2) By Technology: Real-Time Polymerase Chain Reaction, Digital Polymerase Chain Reaction, Conventional Polymerase Chain Reaction
3) By Sample Type: Blood Samples, Saliva Samples, Tissue Samples, Urine Samples
4) By Application: Infectious Disease Testing, Oncology Testing, Other Applications
5) By End-User: Hospitals, Diagnostic Laboratories, Other End Users Subsegments:
1) By Instrument: Standard Polymerase Chain Reaction Systems, Digital Polymerase Chain Reaction Systems, Real-Time Polymerase Chain Reaction Systems
2) By Reagents And Consumables: Polymerase Chain Reaction Kits, Polymerase Chain Reaction Enzymes, Polymerase Chain Reaction Primers and Probes, Polymerase Chain Reaction Master Mix
3) By Software: Polymerase Chain Reaction Analysis Software, Data Management Software
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Becton Dickinson and Company, Laboratory Corporation of America Holdings, Agilent Technologies Inc., Grifols S.A., Illumina Inc., Endress + Hauser AG, bioMereieux SA, Sysmex Corporation, Bio-Rad Laboratories Inc., QuidelOrtho Corporation, PerkinElmer, Eppendorf AG, Tecan Group, Takara Bio Inc., Biocartis NV, Zymo Research Corporation.
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

2. Polymerase Chain Reaction Molecular Diagnostics Market Characteristics

3. Polymerase Chain Reaction Molecular Diagnostics Market Trends And Strategies

4. Polymerase Chain Reaction Molecular Diagnostics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Polymerase Chain Reaction Molecular Diagnostics Growth Analysis And Strategic Analysis Framework

5.1. Global Polymerase Chain Reaction Molecular Diagnostics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Polymerase Chain Reaction Molecular Diagnostics Market Growth Rate Analysis

5.4. Global Polymerase Chain Reaction Molecular Diagnostics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Polymerase Chain Reaction Molecular Diagnostics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Polymerase Chain Reaction Molecular Diagnostics Total Addressable Market (TAM)

6. Polymerase Chain Reaction Molecular Diagnostics Market Segmentation

6.1. Global Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Instrument

Reagents And Consumables

Software

6.2. Global Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Real-Time Polymerase Chain Reaction

Digital Polymerase Chain Reaction

Conventional Polymerase Chain Reaction

6.3. Global Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Blood Samples

Saliva Samples

Tissue Samples

Urine Samples

6.4. Global Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Infectious Disease Testing

Oncology Testing

Other Applications

6.5. Global Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By EndUser, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospitals

Diagnostic Laboratories

Other End Users

6.6. Global Polymerase Chain Reaction Molecular Diagnostics Market, Sub-Segmentation Of Instrument, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Standard Polymerase Chain Reaction Systems

Digital Polymerase Chain Reaction Systems

Real-Time Polymerase Chain Reaction Systems

6.7. Global Polymerase Chain Reaction Molecular Diagnostics Market, Sub-Segmentation Of Reagents And Consumables, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Polymerase Chain Reaction Kits

Polymerase Chain Reaction Enzymes

Polymerase Chain Reaction Primers And Probes

Polymerase Chain Reaction Master Mix

6.8. Global Polymerase Chain Reaction Molecular Diagnostics Market, Sub-Segmentation Of Software, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Polymerase Chain Reaction Analysis Software

Data Management Software

7. Polymerase Chain Reaction Molecular Diagnostics Market Regional And Country Analysis

7.1. Global Polymerase Chain Reaction Molecular Diagnostics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Polymerase Chain Reaction Molecular Diagnostics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Polymerase Chain Reaction Molecular Diagnostics Market

8.1. Asia-Pacific Polymerase Chain Reaction Molecular Diagnostics Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Polymerase Chain Reaction Molecular Diagnostics Market

9.1. China Polymerase Chain Reaction Molecular Diagnostics Market Overview

9.2. China Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Polymerase Chain Reaction Molecular Diagnostics Market

10.1. India Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Polymerase Chain Reaction Molecular Diagnostics Market

11.1. Japan Polymerase Chain Reaction Molecular Diagnostics Market Overview

11.2. Japan Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Polymerase Chain Reaction Molecular Diagnostics Market

12.1. Australia Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Polymerase Chain Reaction Molecular Diagnostics Market

13.1. Indonesia Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Polymerase Chain Reaction Molecular Diagnostics Market

14.1. South Korea Polymerase Chain Reaction Molecular Diagnostics Market Overview

14.2. South Korea Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Polymerase Chain Reaction Molecular Diagnostics Market

15.1. Western Europe Polymerase Chain Reaction Molecular Diagnostics Market Overview

15.2. Western Europe Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Polymerase Chain Reaction Molecular Diagnostics Market

16.1. UK Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Polymerase Chain Reaction Molecular Diagnostics Market

17.1. Germany Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Polymerase Chain Reaction Molecular Diagnostics Market

18.1. France Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Polymerase Chain Reaction Molecular Diagnostics Market

19.1. Italy Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Polymerase Chain Reaction Molecular Diagnostics Market

20.1. Spain Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Polymerase Chain Reaction Molecular Diagnostics Market

21.1. Eastern Europe Polymerase Chain Reaction Molecular Diagnostics Market Overview

21.2. Eastern Europe Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Polymerase Chain Reaction Molecular Diagnostics Market

22.1. Russia Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Polymerase Chain Reaction Molecular Diagnostics Market

23.1. North America Polymerase Chain Reaction Molecular Diagnostics Market Overview

23.2. North America Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Polymerase Chain Reaction Molecular Diagnostics Market

24.1. USA Polymerase Chain Reaction Molecular Diagnostics Market Overview

24.2. USA Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Polymerase Chain Reaction Molecular Diagnostics Market

25.1. Canada Polymerase Chain Reaction Molecular Diagnostics Market Overview

25.2. Canada Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Polymerase Chain Reaction Molecular Diagnostics Market

26.1. South America Polymerase Chain Reaction Molecular Diagnostics Market Overview

26.2. South America Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Polymerase Chain Reaction Molecular Diagnostics Market

27.1. Brazil Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Polymerase Chain Reaction Molecular Diagnostics Market

28.1. Middle East Polymerase Chain Reaction Molecular Diagnostics Market Overview

28.2. Middle East Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Polymerase Chain Reaction Molecular Diagnostics Market

29.1. Africa Polymerase Chain Reaction Molecular Diagnostics Market Overview

29.2. Africa Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Polymerase Chain Reaction Molecular Diagnostics Market Competitive Landscape And Company Profiles

30.1. Polymerase Chain Reaction Molecular Diagnostics Market Competitive Landscape

30.2. Polymerase Chain Reaction Molecular Diagnostics Market Company Profiles

30.2.1. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Becton Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis

31. Polymerase Chain Reaction Molecular Diagnostics Market Other Major And Innovative Companies

31.1. Laboratory Corporation of America Holdings

31.2. Agilent Technologies Inc.

31.3. Grifols S.A.

31.4. Illumina Inc.

31.5. Endress + Hauser AG

31.6. bioMereieux SA

31.7. Sysmex Corporation

31.8. Bio-Rad Laboratories Inc.

31.9. QuidelOrtho Corporation

31.10. PerkinElmer

31.11. Eppendorf AG

31.12. Tecan Group

31.13. Takara Bio Inc.

31.14. Biocartis NV

31.15. Zymo Research Corporation

32. Global Polymerase Chain Reaction Molecular Diagnostics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Polymerase Chain Reaction Molecular Diagnostics Market

34. Recent Developments In The Polymerase Chain Reaction Molecular Diagnostics Market

35. Polymerase Chain Reaction Molecular Diagnostics Market High Potential Countries, Segments and Strategies

35.1 Polymerase Chain Reaction Molecular Diagnostics Market In 2029 - Countries Offering Most New Opportunities

35.2 Polymerase Chain Reaction Molecular Diagnostics Market In 2029 - Segments Offering Most New Opportunities

35.3 Polymerase Chain Reaction Molecular Diagnostics Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Table 3: Global Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 4: Global Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 5: Global Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 6: Global Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 7: Global Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By EndUser, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 8: Global Polymerase Chain Reaction Molecular Diagnostics Market, Sub-Segmentation Of Instrument, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 9: Global Polymerase Chain Reaction Molecular Diagnostics Market, Sub-Segmentation Of Reagents And Consumables, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 10: Global Polymerase Chain Reaction Molecular Diagnostics Market, Sub-Segmentation Of Software, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 11: Global Polymerase Chain Reaction Molecular Diagnostics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 12: Global Polymerase Chain Reaction Molecular Diagnostics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 13: Asia-Pacific, Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 14: Asia-Pacific, Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 15: Asia-Pacific, Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 16: China, Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 17: China, Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 18: China, Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 19: India, Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 20: India, Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 21: India, Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 22: Japan, Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 23: Japan, Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 24: Japan, Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 25: Australia, Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 26: Australia, Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 27: Australia, Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 28: Indonesia, Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 29: Indonesia, Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 30: Indonesia, Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 31: South Korea, Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 32: South Korea, Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 33: South Korea, Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 34: Western Europe, Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 35: Western Europe, Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 36: Western Europe, Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 37: UK, Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 38: UK, Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 39: UK, Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 40: Germany, Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 41: Germany, Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 42: Germany, Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 43: France, Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 44: France, Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 45: France, Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 46: Italy, Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 47: Italy, Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 48: Italy, Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 49: Spain, Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 50: Spain, Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 51: Spain, Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 52: Eastern Europe, Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 53: Eastern Europe, Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 54: Eastern Europe, Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 55: Russia, Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 56: Russia, Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 57: Russia, Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 58: North America, Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 59: North America, Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 60: North America, Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 61: USA, Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 62: USA, Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 63: USA, Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 64: Canada, Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 65: Canada, Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 66: Canada, Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 67: South America, Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 68: South America, Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 69: South America, Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 70: Brazil, Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 71: Brazil, Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 72: Brazil, Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 73: Middle East, Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 74: Middle East, Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 75: Middle East, Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 76: Africa, Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 77: Africa, Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 78: Africa, Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 79: F. Hoffmann-La Roche AG Financial Performance
  • Table 80: Thermo Fisher Scientific Inc. Financial Performance
  • Table 81: Abbott Laboratories Financial Performance
  • Table 82: Danaher Corporation Financial Performance
  • Table 83: Becton Dickinson and Company Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Figure 3: Global Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 4: Global Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 5: Global Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 6: Global Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 7: Global Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By EndUser, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 8: Global Polymerase Chain Reaction Molecular Diagnostics Market, Sub-Segmentation Of Instrument, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 9: Global Polymerase Chain Reaction Molecular Diagnostics Market, Sub-Segmentation Of Reagents And Consumables, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 10: Global Polymerase Chain Reaction Molecular Diagnostics Market, Sub-Segmentation Of Software, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 11: Global Polymerase Chain Reaction Molecular Diagnostics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 12: Global Polymerase Chain Reaction Molecular Diagnostics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 13: Asia-Pacific, Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 14: Asia-Pacific, Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 15: Asia-Pacific, Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 16: China, Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 17: China, Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 18: China, Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 19: India, Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 20: India, Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 21: India, Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 22: Japan, Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 23: Japan, Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 24: Japan, Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 25: Australia, Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 26: Australia, Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 27: Australia, Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 28: Indonesia, Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 29: Indonesia, Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 30: Indonesia, Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 31: South Korea, Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 32: South Korea, Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 33: South Korea, Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 34: Western Europe, Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 35: Western Europe, Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 36: Western Europe, Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 37: UK, Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 38: UK, Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 39: UK, Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 40: Germany, Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 41: Germany, Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 42: Germany, Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 43: France, Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 44: France, Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 45: France, Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 46: Italy, Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 47: Italy, Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 48: Italy, Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 49: Spain, Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 50: Spain, Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 51: Spain, Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 52: Eastern Europe, Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 53: Eastern Europe, Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 54: Eastern Europe, Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 55: Russia, Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 56: Russia, Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 57: Russia, Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 58: North America, Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 59: North America, Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 60: North America, Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 61: USA, Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 62: USA, Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 63: USA, Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 64: Canada, Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 65: Canada, Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 66: Canada, Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 67: South America, Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 68: South America, Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 69: South America, Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 70: Brazil, Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 71: Brazil, Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 72: Brazil, Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 73: Middle East, Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 74: Middle East, Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 75: Middle East, Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 76: Africa, Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 77: Africa, Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 78: Africa, Polymerase Chain Reaction Molecular Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 79: F. Hoffmann-La Roche AG Financial Performance
  • Figure 80: Thermo Fisher Scientific Inc. Financial Performance
  • Figure 81: Abbott Laboratories Financial Performance
  • Figure 82: Danaher Corporation Financial Performance
  • Figure 83: Becton Dickinson and Company Financial Performance

Frequently Asked Questions

Polymerase chain reaction (PCR) molecular diagnostics is a laboratory technique used to amplify and analyze specific deoxyribonucleic acid or ribonucleic acid sequences in a sample. Its main purpose is to detect the presence of specific genetic material, enabling the identification of pathogens, genetic disorders, or mutations. It is widely used in medical diagnostics for detecting infectious diseases, genetic disorders, and cancer markers with high sensitivity and accuracy. For further insights on this market, request a sample here

The market major growth driver - Rising Prevalence Of Infectious Diseases Fueling The Growth Of The Market Due To Increasing Need For Early And Accurate Pathogen Detection. For further insights on this market, request a sample here

The polymerase chain reaction molecular diagnostics market size has grown strongly in recent years. It will grow from $8.97 billion in 2024 to $9.75 billion in 2025 at a compound annual growth rate (CAGR) of 8.6%. The growth in the historic period can be attributed to increasing demand for early disease detection, increasing prevalence of infectious diseases, increasing awareness of genetic disorders, rising adoption of point-of-care testing, and increasing incidence of chronic diseases. The polymerase chain reaction molecular diagnostics market size is expected to see strong growth in the next few years. It will grow to " $13.54 billion in 2029 at a compound annual growth rate (CAGR) of 8.6%. The growth in the forecast period can be attributed to the rising prevalence of cancer, growing demand for personalized medicine, increasing investments in molecular diagnostics, rising demand for rapid diagnostic tests, and growing demand for non-invasive prenatal testing. Major trends in the forecast period include the advancement of diagnostic technologies, the development of point-of-care polymerase chain reaction systems, innovation in multiplex polymerase chain reaction, the integration of polymerase chain reaction with microfluidics, and technology upgrades in digital polymerase chain reaction platforms. For further insights on this market, request a sample here

The polymerase chain reaction molecular diagnosticsmarket covered in this report is segmented –
1) By Product Type: Instrument; Reagents And Consumables; Software
2) By Technology: Real-Time Polymerase Chain Reaction; Digital Polymerase Chain Reaction; Conventional Polymerase Chain Reaction
3) By Sample Type: Blood Samples; Saliva Samples; Tissue Samples; Urine Samples
4) By Application: Infectious Disease Testing; Oncology Testing; Other Applications
5) By End-User: Hospitals; Diagnostic Laboratories; Other End Users Subsegments:
1) By Instrument: Standard Polymerase Chain Reaction Systems; Digital Polymerase Chain Reaction Systems; Real-Time Polymerase Chain Reaction Systems
2) By Reagents And Consumables: Polymerase Chain Reaction Kits; Polymerase Chain Reaction Enzymes; Polymerase Chain Reaction Primers and Probes; Polymerase Chain Reaction Master Mix
3) By Software: Polymerase Chain Reaction Analysis Software; Data Management Software For further insights on this market,
request a sample here

North America was the largest region in the polymerase chain reaction molecular diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the polymerase chain reaction molecular diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on this market, request a sample here.

Major companies operating in the polymerase chain reaction molecular diagnostics market are F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Becton Dickinson and Company, Laboratory Corporation of America Holdings, Agilent Technologies Inc., Grifols S.A., Illumina Inc., Endress + Hauser AG, bioMereieux SA, Sysmex Corporation, Bio-Rad Laboratories Inc., QuidelOrtho Corporation, PerkinElmer, Eppendorf AG, Tecan Group, Takara Bio Inc., Biocartis NV, Zymo Research Corporation. . For further insights on this market, request a sample here.

Major trends in this market include Advancements in Digital Technology Enhance Precision and Speed in Disease Detection. For further insights on this market, request a sample here.

Customer representative image Book your 30 minutes free consultation with our research experts
Back to top WhatsApp icon